Table: SymBio Pharmaceuticals - Q1 parent results

SymBio Pharmaceuticals

12/05/2020 07:30

May 12 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Mar 31, 2020        Mar 31, 2019       Dec 31, 2020  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            551 mln              1.61               3.40      
                 (-65.8 pct)         (+81.4 pct)       (+20.0 pct)   
  Operating     loss 961 mln        loss 595 mln        loss 5.09    
  Recurring     loss 991 mln        loss 616 mln        loss 5.13    
  Net           loss 992 mln        loss 616 mln        loss 4.80    
  EPS          loss 35.84 yen      loss 29.92 yen    loss 158.98 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T